Kristian Reich

Translational Research in Inflammatory Skin Diseases, Institute for Health Services Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf , Hamburg , Germany

ORCID: 0000-0001-5248-4332

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Sonelokimab, an IL-17A/IL-17F-inhibiting nanobody for active psoriatic arthritis: a randomized, placebo-controlled phase 2 trial”.

Sonelokimab, an IL-17A/IL-17F-inhibiting nanobody for active psoriatic arthritis: a randomized, placebo-controlled phase 2 trial

Nature Medicine(2025)10.1038/s41591-025-03971-6

N/A

0.408DataRank · unranked

13 citations

Laura C. Coates, Philip J. Mease, Alexis Ogdie, Arthur Kavanaugh, Lihi Eder +10 more

394 Gene expression based molecular test proves clinical validity as diagnostic aid for the differential diagnosis of psoriasis and eczema in formalin fixed and paraffin embedded tissue

British Journal of Dermatology(2023)10.1093/bjd/ljad162.019

N/A

0.104DataRank · unranked

1 citations

Anais Doll, Deniz Uereyener, Sophie Roenneberg, Christina Hillig, Lucca Weber +18 more